WAP
ONC icon

Wealthcare Advisory Partners’s BeOne Medicines Ltd ONC Stock Holding History

Wealthcare Advisory Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-500
Closed -$84K – 1325
2018
Q1 		$84K Buy
+500
New +$67.7K 0.02% 314

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wealthcare Advisory Partners's ONC Position: Q2 2018 in Review

Wealthcare Advisory Partners sold out of BeOne Medicines Ltd (ONC) in Q2 2018, closing a stake of 500 shares — an estimated $84K sold.

Wealthcare Advisory Partners first reported a position in ONC in Q1 2018 and held it in 1 quarter. The position peaked at $84K in Q1 2018. 128 funds tracked by Wall St. Rank hold ONC as of Q2 2018.

  • Wealthcare Advisory Partners reported no remaining BeOne Medicines Ltd position as of Q2 2018 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 500 BeOne Medicines Ltd shares in Q2 2018, an estimated $84K.
  • Wealthcare Advisory Partners first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 1 quarter.
  • Wealthcare Advisory Partners's BeOne Medicines Ltd position peaked at $84K in Q1 2018.
  • 128 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2018.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2018, filed 14 Aug 2018.